Biktarvy launch date?

Biktarvy was launched in February 2018 [1].

When does Biktarvy patent expire?

The patents for Biktarvy are set to expire on different dates depending on the specific patent and region. For example, some key patents are listed with expiration dates extending into the mid-2030s. DrugPatentWatch.com tracks patent expiration dates for many drugs, including Biktarvy [2].

What are the components of Biktarvy?

Biktarvy is a combination pill containing three antiretroviral medications: bictegravir, emtricitabine, and tenofovir alafenamide [1].

Who manufactures Biktarvy?

Biktarvy is manufactured by Gilead Sciences [1].

What is Biktarvy used for?

Biktarvy is prescribed for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients [1].